4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-049394
Chief Business Officer sold 6,943 shares at $39.15 ($271,796)
- Chief Business Officer acquired 6,943 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Parrish Jay · Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-01 | Exercise or conversion : show line 1 in the form | +6,943 | $1.58 | $10,935 | 229,165 | D |
| 2020-09-01 | Sale : show line 2 in the form | −6,943 | $39.15 | $271,796 | 222,222 | D |
| Open-market sales · 6,943 sh · avg $39.15 · $271,796 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-09-01 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −6,943 | 53,241 | D |
Loading xslF345X03/doc4.xml…